The Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in France

Study Identifier
P15-405
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Protocol
Available Language(s): English
Statistical Analysis Plan
Available Language(s): English
Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Hepatitis
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years

    Protocol Summary

    This study seeks to determine the effectiveness of the interferon-free ABBVIE REGIMEN ± ribavirin (RBV) in participants with chronic hepatitis C (CHC) virus in clinical practices across France.

    Study Locations

    Location
    Status
    Location
    Hopital Saint Joseph /ID# 144927
    Marseille, Bouches-du-Rhone, France, 13285
    Status
    Not applicable
    Location
    Hopital Saint Joseph /ID# 145560
    Marseille, Bouches-du-Rhone, France, 13285
    Status
    Not applicable
    Location
    Hopital Saint Joseph /ID# 145571
    Marseille, Bouches-du-Rhone, France, 13285
    Status
    Not applicable
    Location
    CHR Orleans - Hopital de la Source /ID# 147250
    Orléans, Centre-Val De Loire, France, 45067
    Status
    Not applicable
    Location
    CHU de Besancon - Jean Minjoz /ID# 145884
    Besançon, Doubs, France, 25000
    Status
    Not applicable
    Location
    CHU Dupuytren /ID# 144920
    Limoges, Franche-Comte, France, 87042
    Status
    Not applicable
    Showing {first} - {last} of {total} Results